[PDF][PDF] What remains against carbapenem-resistant Enterobacteriaceae and Acinetobacter spp? Evaluation of Tigecycline and Colistin

WH Amer - Int J Curr Microbiol Appl Sci, 2015 - researchgate.net
What remains against carbapenem-resistant Enterobacteriaceae and Acinetobacter spp?
Evaluation of Tigecycline and Colistin Page 1 Int.J.Curr.Microbiol.App.Sci (2015) 4(9): 613-624 …

Emergence of Tigecycline and Colistin Resistance in Acinetobacter Species Isolated from Patients in Kuwait Hospitals

NA Al-Sweih, MA Al-Hubail, VO Rotimi - Journal of Chemotherapy, 2011 - Taylor & Francis
The development of resistance is a compelling reason for reviewing administration of
antibiotics. Recently, most Acinetobacter infections are caused by multidrug-resistant (MDR) …

Treatment options for carbapenem-resistant gram-negative bacterial infections

Y Doi - Clinical Infectious Diseases, 2019 - academic.oup.com
Antimicrobial resistance has become one of the greatest threats to public health, with rising
resistance to carbapenems being a particular concern due to the lack of effective and safe …

[HTML][HTML] Study on MICs of tigecycline in clinical isolates of carbapenem resistant Enterobacteriaceae (CRE) at a tertiary care centre in North India

V Khare, P Gupta, F Haider… - Journal of clinical and …, 2017 - ncbi.nlm.nih.gov
Aim To evaluate the MIC values of tigecycline against carbapenem resistant Escherichia coli
and Klebsiella pneumoniae isolates. Materials and Methods This prospective study was …

In vitro activity of tigecycline and comparators against carbapenem-resistant Enterobacteriaceae in Africa–Middle East countries: TEST 2007–2012

MI Renteria, DJ Biedenbach, SK Bouchillon… - Journal of Global …, 2014 - Elsevier
Multidrug-resistant (MDR) Enterobacteriaceae are an emerging concern for healthcare
providers. Infections caused by MDR pathogens are associated with increased costs, length …

Colistin and tigecycline resistance in carbapenem-resistant Enterobacteriaceae: Checkmate to our last line of defense

M Kumar - Infection Control & Hospital Epidemiology, 2016 - cambridge.org
To the Editor—The emergence and spread of antimicrobial drug resistance in
Enterobacteriaceae is posing a serious threat to the treatment of nosocomial infections. Of …

In vitro activities of 'new'and 'conventional'antibiotics against multidrug resistant Gram negative bacteria from patients in the intensive care unit

I Ratnam, C Franklin, DW Spelman - Pathology, 2007 - Elsevier
Objectives To identify and collect clinical isolates of multidrug resistant Gram negative
bacteria and to perform antimicrobial susceptibility testing using an extended panel of …

Present and future of carbapenem-resistant Enterobacteriaceae infections

B Suay-García, MT Pérez-Gracia - Advances in clinical …, 2021 - taylorfrancis.com
This chapter analyzes the epidemiology of Carbapenem-Resistant Enterobacteriaceae
(CRE) as well as current and future treatment options against the increasingly resistant …

Comparative evaluation of tigecycline susceptibility testing methods for Acinetobacter baumannii and Enterobacteriaceae

J Zhang, C Zhao, H Chen, X Wang, H Li… - Journal of global …, 2015 - Elsevier
The objectives of this study were to recommend suitable susceptibility testing methods for
tigecycline for clinical laboratory use and to evaluate differences in tigecycline susceptibility …

Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013)

HS Sader, M Castanheira, RK Flamm… - … and infectious disease, 2015 - Elsevier
We evaluated the in vitro activity of tigecycline and selected comparator agents tested
against carbapenem-resistant Enterobacteriaceae (CRE) isolated from European medical …